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Relationships between cancer pattern, country
income and geographical region in Asia
Chirk Jenn Ng1*, Chin Hai Teo1, Nurdiana Abdullah1, Wei Phin Tan2 and Hui Meng Tan1,3
Abstract
Background: Cancer incidence and mortality varies across region, sex and country’s economic status. While most
studies focused on global trends, this study aimed to describe and analyse cancer incidence and mortality in Asia,
focusing on cancer site, sex, region and income status.
Methods: Age-standardised incidence and mortality rates of cancer were extracted from the GLOBOCAN 2012
database. Cancer mortality to incidence ratios (MIRs) were calculated to represent cancer survival. The data were
analysed based on the four regions in Asia and income.
Results: Cancer incidence rate is lower in Asia compared to the West but for MIR, it is the reverse. In Asia, the most
common cancers in men are lung, stomach, liver, colorectal and oesophageal cancers while the most common
cancers in women are breast, lung, cervical, colorectal and stomach cancers. The MIRs are the highest in lung, liver
and stomach cancers and the lowest in colorectal, breast and prostate cancers. Eastern and Western Asia have a
higher incidence of cancer compared to South-Eastern and South-Central Asia but this pattern is the reverse for
MIR. Cancer incidence rate increases with country income particularly in colorectal and breast cancers but the
pattern is the opposite for MIR.
Conclusion: This study confirms that there is a wide variation in cancer incidence and mortality across Asia. This
study is the first step towards documenting and explaining the changing cancer pattern in Asia in comparison to
the rest of the world.
Background
Recent studies have found that developing countries,
particularly those in Asia, are facing a rising cancer inci-
dence. The incidence rates of cancers such as lung and
colorectal in some Asian countries have surpassed that
of Western countries [1, 2]. This change may be due to
the adoption of cancer-related lifestyle such as smoking,
alcohol consumption, physical inactivity, obesity and
high-fat, low-fibre diet [3]; environmental and occupa-
tional risk factors such as air pollution, indoor smoke
from household use of solid fuel; and contaminated
injections in healthcare settings [4].
Currently, Asia contributes to 48 % of the total num-
ber of new cancer cases in the world, of which nearly
half are found in China. Similarly, the cancer deaths in
Asia constitute 55 % of that in the world. The cancer in-
cidence and mortality in Asia are expected to rise over
the next two decades [3]. Asia, comprising mainly
developing countries, is also facing a rapid population
expansion. This rising cancer incidence would have a
significant impact on healthcare burden and individuals’
quality of life across Asia [5].
Previous global studies have found that cancer inci-
dence and mortality vary according to age distribution,
sex, location and economic status of a country [1, 2].
Globally, men have been found to have high cancer inci-
dence and mortality rates compared to women [6, 7].
The incidences of cancers in developed countries are
higher compared to less developed countries; however,
the former have a better survival rate [8]. In addition,
many studies have shown wide variations in cancer rates
across different parts of the world; some even showing
conflicting incidence within the same region [1, 9]. How-
ever, most of these studies focused on global trends [1, 9],
specific sub-regions of Asia [10] or specific cancer types
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[11, 12]; there is limited literature on overall cancer
epidemiology in Asia.
Therefore, this study, based on the latest GLOBOCAN
2012 data, aimed to describe and analyse the incidence
and mortality of cancer in Asia, according to cancer
type, sex, region and income status. We believe that this
is the first step towards documenting and explaining the
changing cancer pattern in Asia in comparison to the
rest of the world.
Methods
We extracted the cancer data for Asia from GLOBOCAN
2012, which provides updated national level cancer statis-
tics for 184 countries in the world [3]. GLOBOCAN uses
several estimation methods to produce country-specific
incidence and mortality data. For cancer incidence,
GLOBOCAN first attempted to obtain the data from
the Cancer Incidence in Five Continents (CI5) [13, 14].
If they were not available, national, regional or frequency
data were estimated. Similarly, for cancer mortality, GLO-
BOCAN used national vital registration data from the
World Health Organization Statistical Information System
where available; otherwise mortality rates were estimated
[15]. The data sources and methods for estimating inci-
dence and mortality rates for each country can be found
at the GLOBOCAN website [16] and is summarised in
Additional file 1. We did not seek ethics approval in this
study because we used population-based secondary data
from the GLOBOCAN database, which is openly access-
ible to the public. In addition, the study did not directly
involve any individual human subject or identifiable data.
We used age-standardised rates (ASR) to compare the
incidence and mortality rates between countries and the
ASR were calculated using the World Standard Popula-
tion and expressed as per 100,000 person-years [17]. Mor-
tality to incidence ratio (MIR) was used as an indirect
measure of cancer survival and an MIR of 1.0 indicates no
survival [8].
A total of 47 Asian countries were included in this
study and they were divided into four subregions accord-
ing to the United Nation World Population Prospects
2012: Eastern (n = 5), South-Eastern (n = 11), South-
Central (n = 14) and Western (n = 17) Asia [18] (Fig. 1).
We used the gross national income (GNI) per capita for
income analysis which is based on the World Bank Atlas
methodology (US dollars) [19]. The country income was
analysed as a continuous variable and we used linear
correlation coefficient to determine the relationships be-
tween income and cancer incidence, mortality and MIR.
Results
Cancer incidence, mortality and MIR: Asia vs other
continents
Asia has a lower overall cancer incidence rate (152.2/
100,000; ranked 5/6) compared to more developed conti-
nents such as North America (315.6/100,000), Oceania
Fig. 1 Countries by region in Asia according to United Nation World Population Prospects 2012 [18]
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(298.4/100,000) and Europe (255.4/100,000) (Table 1).
This pattern is observed in both sexes; however men
have a higher incidence of cancer compared to women
both in Asia and other continents, except for Africa
(women 132.4/100,000 vs men 115.6/100,000).
Similarly, the overall mortality rate in Asia (100.1/
100,000; ranked 4/6) was lower than Europe (113.1/
100,000), North America (105.5/100,000) and Oceania
(102.5/100,000). However, the pattern is the reverse for
overall MIR, which is found to be higher in Asia (0.66;
ranked 2/6) compared to North America (0.33), Oceania
(0.34) and Europe (0.44). This pattern is also observed in
both sexes whereby men have a higher MIR compared
to women across all continents.
Cancer incidence and MIR by sex and cancer site in Asia
The most common cancer in men is lung cancer
(35.2/100,000), followed by stomach (22.8/100,000),
liver (20.0/100,000), colorectal (16.5/100,000) and
oesophageal (11.4/100,000) cancers. For women, the most
common cancer is breast cancer (29.1/100,000), followed
by lung (12.7/100,000), cervical (12.7/100,000), colorectal
(11.1/100,000) and stomach (9.3/100,000) cancers
(Fig. 2). The cancer incidence is higher in men com-
pared to women in all sites except for gallbladder (male
2.5/100,000; female 2.7/100,000) and thyroid (male 1.5/
100,000; female 5.0/100,000) cancers.
For male-specific cancers, prostate cancer is the most
common (9.4/100,000) in Asia and it ranked sixth
among all the cancers in men. The most common
female-specific cancer is breast cancer (29.1/100,000),
followed by cervical (12.7/100,000), endometrial (5.9/
100,000) and ovarian (5.0/100,000) cancers.
In Asia, the cancer MIRs are the highest in lung (male
0.90; female 0.87), liver (male 0.95; female 0.96) and
stomach (male 0.73; female 0.76) cancers. In comparison,
colorectal (male 0.52; female 0.54), breast (0.35) and
prostate (0.40) cancers have lower MIRs.
Top five cancer incidence, mortality and MIR in Asia by
sex and sub-region
All cancers
Overall, the cancer incidence and mortality rates are the
highest in East Asia (incidence 186/100,000; mortality
117.7/100,000), followed by West (incidence 168.2/
100,000; mortality 103/100,000), South-Eastern (incidence
138.2/100,000; mortality 94.8/100,000) and South-Central
(incidence 100.1/100,000; mortality 69.3/100,000) Asia
(Table 2). For the MIR, Western Asia (0.61) has the lowest
MIR, followed by Eastern (0.63), South-Eastern (0.69) and
South-Central (0.69) Asia. In terms of sex, the overall can-
cer incidence rates are lower in women compared to men
in all sub-regions except South-Central Asia. Similarly, the
mortality rates and MIRs are observed to be lower in
women for all sub-regions.
Lung cancer
Lung cancer has the highest incidence and mortality
rates among men for all sub-regions. For both sexes,
Eastern Asia has the highest incidence rate (male 50.4/
100,000; female 19.2/100,000) whereas South-Central
Asia has the lowest incidence rate (male 11.9/100,000;
female 3.4/100,000). However, the pattern is the reverse
for MIR where Eastern Asia has the lowest MIR (0.84)
whereas South-Central Asia has the highest MIR (0.91).
Breast cancer
The incidence of breast cancer is the highest in Western
Asia (42.8/100,000), followed by South-Eastern (34.8/
100,000), South-Central (28.2/100,000) and Eastern (27.0/
100,000) Asia. Conversely, breast cancer MIR is the lowest in
Eastern Asia (0.23) and highest in South-Central Asia (0.48).
Cervical cancer
South-Central Asia has the highest cervical cancer inci-
dence rate (19.3/100,000), followed by South-Eastern
(16.3/100,000), Eastern (7.9/100,000) and Western (4.4/
100,000) Asia. South-Central Asia has the highest MIR
Table 1 Comparison of overall and sex-specific age-standardised incidence, mortality and MIR of all cancers across six continents
All cancers excluding
non-melanoma skin cancer
Age-standardized rate (per 100,000 person-years)
Overall Male Female
Continent Inc Mor MIR Inc Mor MIR Inc Mor MIR
Northern America 315.6 105.5 0.33 344.2 123.2 0.36 295.4 91.7 0.31
Oceania 298.4 102.5 0.34 338.5 117.8 0.35 264.8 90.0 0.34
Europe 255.4 113.1 0.44 298.9 147.5 0.49 226.7 87.6 0.39
Latin America and Caribbean 177.0 94.9 0.54 187.6 108.4 0.58 170.7 84.7 0.50
Asia 152.2 100.1 0.66 174.1 126.3 0.73 134.3 77.0 0.57
Africa 123.4 89.9 0.73 115.6 92.9 0.80 132.4 88.7 0.67
World 182.3 102.4 0.56 205.4 126.3 0.61 165.3 82.9 0.50
Inc Incidence, Mor Mortality, MIR Mortality to incidence ratio
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(0.56) while Eastern Asia has the lowest MIR (0.42) for
cervical cancer.
Colorectal cancer
Eastern Asia has the highest incidence of colorectal can-
cer (male 22.4/100,000; female 14.6/100,000) with the
lowest MIR (male 0.46; female 0.47) for both men and
women in Asia. Conversely, the lowest incidence of
colorectal cancer is found in South-Central Asia (male
7.0/100,000; female 5.2/100,000), which also has the
highest MIR (male 0.73; female 0.73).
Liver cancer
Liver cancer is one of the top five cancers among Asian
men. It is particularly common in Eastern (31.9/100,000)
and South-Eastern (22.2/100,000) Asia compared to South-
Central (3.7/100,000) and Western (5.0./100,00) Asia. The
MIRs are high in all sub-regions of Asia (range 0.94–0.98).
Stomach cancer
Eastern Asia has the highest incidence of stomach cancer
for both men (35.4/100,000) and women (13.8/100,000)
while the incidence is the lowest in South-Eastern (male
8.2/100,000; female 4.1/100,000) and South-Central (male
9.2/100,000; female 4.2/100,000) Asia. However, the MIR
is the lowest in Eastern Asia (male 0.68; female 0.71) com-
pared to South-Central Asia, which has the highest MIR
(male 0.92; female 0.93) for stomach cancer.
Oesophageal cancer
Oesophageal cancer is also common among Asian men
with the incidence being the highest in Eastern Asia
(16.9/100,000) and it is less common in other sub-regions
of Asia (Western 2.9/100,000; South-Eastern 3.3/100,000;
South-Central 6.5/100,000). Although, Eastern Asia has
the highest incidence of oesophageal cancer, it has the
lowest MIR (0.83) in Asia.
Top five cancer incidence, mortality and MIR in Asia by
sex and country income group
Top five cancers in men
In Asia, the incidence of colorectal cancer increases with
country income (r = 0.519, p < 0.0005) but the pattern is
the opposite for oesophageal cancer (r = −0.369, p = 0.011)
Fig. 2 Comparison of age-standardised cancer incidence, mortality and MIR in Asia by sex and cancer site
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in men (Table 3); however, this is not observed in lung,
liver and stomach cancers. For mortality, there is a posi-
tive correlation between colorectal cancer and country in-
come group (r = 0.307, p = 0.036) and the reverse pattern
is observed in oesophageal cancer (r = −0.388, p = 0.007).
The MIR is lower in higher income countries for stomach
(r = −0.584, p < 0.0005) and colorectal (r = −0.751, p <
0.0005) cancers (Fig. 3). This pattern is not observed
in lung, oesophageal and liver cancers.
Top five cancers in women
For Asian women, the incidence of breast (r = 0.534, p <
0.0005) and colorectal (r = 0.604, p < 0.0005) cancer in-
creases with country income (Table 3), while the reverse
is true for cervical cancer (r = 0.354, p = 0.015). For
mortality, it is higher in women with cervical cancer
from lower income countries (r = −0.528, p < 0.0005) but
the reverse pattern is observed in colorectal cancer (r =
0.463, p = 0.001). There is an inverse correlation between
MIR and income group for breast (r=−0.791, p < 0.0005),
cervical (r=−0.642, p < 0.0005), colorectal (r=−0.702, p <
0.0005), and stomach (r=−0.627, p < 0.0005) cancers (Fig. 4).
Discussion
This study highlights a few interesting patterns of cancer
incidence and MIR in Asia: (1) Asia has one of the low-
est incidence of overall cancer rates but it has the sec-
ond highest MIR in the world; (2) There are similarities
in the leading cancers diagnosed in Asia and those in
more developed continents such as Australia, Europe
Table 2 Comparison of age-standardised incidence, mortality and MIR of all (excluding non-melanoma skin cancer) and top five
cancers in Asia by sub-regions
Age-standardized rate (per 100,000 person-years)
Region Eastern Asia South-Eastern Asia South-Central Asia Western Asia
Cancer site Inc Mor MIR Inc Mor MIR Inc Mor MIR Inc Mor MIR
Both sexes
All cancers 186.0 117.7 0.63 138.2 94.8 0.69 100.1 69.3 0.69 168.2 103.0 0.61
Male
All cancers 225.4 159.3 0.71 147.6 114.1 0.77 98.4 74.8 0.76 192.8 129.3 0.67
Lung 50.4 44.8 0.89 29.6 26.6 0.90 11.9 10.7 0.90 37.6 34.0 0.90
Stomach 35.4 24.0 0.68 8.2 7.3 0.89 9.2 8.5 0.92 11.8 10.2 0.86
Liver 31.9 29.9 0.94 22.2 21.4 0.96 3.7 3.6 0.97 5.0 4.9 0.98
Colorectum 22.4 10.2 0.46 15.2 9.7 0.64 7.0 5.1 0.73 17.6 10.0 0.57
Oesophagus 16.9 14.1 0.83 3.6 3.3 0.92 6.5 6.0 0.92 2.9 2.7 0.93
Female
All cancers 151.9 80.2 0.53 132.6 79.5 0.60 103.3 64.7 0.63 150.2 81.3 0.54
Breast 27.0 6.1 0.23 34.8 14.1 0.41 28.2 13.5 0.48 42.8 15.1 0.35
Lung 19.2 16.2 0.84 10.5 9.4 0.90 3.4 3.1 0.91 7.1 6.2 0.87
Cervix 7.9 3.3 0.42 16.3 7.9 0.48 19.3 10.9 0.56 4.4 1.9 0.43
Colorectum 14.6 6.8 0.47 10.2 6.4 0.63 5.2 3.8 0.73 12.4 7.1 0.57
Stomach 13.8 9.8 0.71 4.1 3.5 0.85 4.2 3.9 0.93 7.3 6.2 0.85
Inc Incidence, Mor Mortality, MIR Mortality to incidence ratio
Table 3 Correlation between GNI per capita and incidence and mortality of all and top five cancers in men and woman in Asia
Male Female
Cancer site Correlation coefficient Cancer site Correlation coefficient
Inc p Mor p Inc p Mor p
All cancers 0.240 0.104 −0.225 0.129 All cancers 0.177 0.234 −0.163 0.272
Lung 0.173 0.246 0.152 0.307 Breast 0.534 <0.0005 0.013 0.928
Stomach −0.072 0.631 −0.207 0.162 Lung 0.142 0.340 0.122 0.415
Liver −0.060 0.689 −0.068 0.648 Cervix −0.354 0.015 −0.528 <0.0005
Colorectum 0.519 <0.0005 0.307 0.036 Colorectum 0.604 <0.0005 0.463 0.001
Oesophagus −0.369 0.011 −0.388 0.007 Stomach 0.030 0.840 −0.142 0.340
Inc Incidence, Mor Mortality, p p-value
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Fig. 3 Comparison of top five male cancers MIR to GNI per capita in Asian countries
Fig. 4 Comparison of top five female cancers MIR to GNI per capita in Asian countries
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and Northern America, apart from prostate, cervical and
liver cancers. For men, prostate cancer is the most com-
mon cancer in the developed countries while liver cancer
is relatively more common in Asia. For women, cervical
and liver cancer are more common in Asia compared to
the developed countries; (3) there is a variation in the
cancer incidence and MIR across different sub-regions of
Asia, with Eastern and Western Asia having a higher can-
cer incidence and lower MIR compared to South-Eastern
and South-Central Asia.
Globally, the incidence of and mortality attributed to
cancer are rising which is most likely due to ageing
population as well as reductions in childhood mortality
and deaths related to infectious diseases, such as respira-
tory and gastrointestinal infections [20–23]. However,
there are significant differences in cancer burden across
the world and they are mainly attributed to the variation
in the age structure; prevalence of risk factors such as
nutrition and diet, infection and tobacco; environmental
and occupational factors; availability and use of cancer
screening services; and access to and quality of the can-
cer treatment [4, 9, 24–26]. Asia, which comprises
mostly developing countries, has been having a steady
rise in the incidence of cancer over the years [9]. Breast,
lung, stomach, colorectal and liver cancers constitute
the most common cancers in Asia.
Prostate cancer is the most common male-specific
cancer in Asia and it ranks sixth among all cancers in
Asian men, compared to developed countries where
prostate cancer is the most common cancer among men
[1, 3]. It has been well established that Asian particularly
Chinese men have a lower risk of prostate cancer com-
pared to black and white men [27]. In fact, recently,
there is an observed rise in the incidence of prostate
cancer in countries such as the Philippines, Japan, China
and Singapore and this is most likely due to the
increased uptake of prostate specific antigen (PSA)
screening [1, 3, 28]. The most common female-specific
cancer in Asia is breast cancer, which is also the most
common cancer among Asian women; this is followed
by cervical, endometrial and ovarian cancer. This pattern
is similar to those of the developed countries except for
endometrial cancer which is more common than cervical
cancer in the developed countries [1, 3].
Nasopharyngeal cancer are more commonly seen in
the Asian population compared to those in other conti-
nents. South-Eastern Asia countries, such as Malaysia,
Vietnam, Singapore and Indonesia, contribute to most
of the nasopharyngeal cancer cases, which are associated
with Epstein-Barr virus, consumption of preserved food,
tobacco use and genetic factors [29]. The incidence rate
for lip and oral cancers is also high in South Asian coun-
tries such as Sri Lanka, Pakistan, Bangladesh and India,
contributing to most of the cases in Asia [3]. Aetiological
agents for lip and oral cancers such as betel quid and
areca nut chewing are commonly practised by the South
Asians. Other risk factors include smoking, alcohol use,
human papillomavirus (HPV) infection, obesity and gen-
etic factors [30].
In this study, one striking finding is the high cancer
incidence in Eastern and Western Asia and this is ob-
served in both sex- and non-sex specific cancers (except
cervical cancer). It is likely that lifestyle differences
between these sub-regions contribute to the variation in
cancer incidence. For instance, the prevalence of cigarette
smoking among men is much higher in China (57.4 %)
compared to India (32.7 %) and Pakistan (27.3 %) [31].
This can explain the relative higher incidence of lung and
oesophageal cancer in Eastern Asia. Increasingly, the de-
veloped and developing countries in Asia are adopting a
more Westernised lifestyle, which include a high fat, low
fibre diet [32]. Countries in East Asia, such as Japan and
South Korea, see a rise in the incidence of colorectal
cancer, which is associated with a low-fibre diet [8]. A
high-fat, high calorie diet and sedentary lifestyle in some
Asian countries also contributed to the rising incidence of
obesity, which is associated with breast cancer [33, 34]. In
some Asian population, such as the Chinese, weight gain
is related to an increased risk of postmenopausal breast
cancer even in relatively thin women [35]. This may
explain the observed high incidence of breast cancer in
Western Asia, which has among the highest prevalence of
female obesity in Asia [36]. Environmental factors such as
air pollution may also play an important role as the devel-
oping countries become more industrialised [4].
The high incidence of oesophageal cancer, particularly
squamous cell carcinoma, is likely to be associated with
higher alcohol consumption [37], which is seen in some
Eastern Asian countries [38, 39]. For example, between
2008 and 2010, the total adult per capita consumption
of pure alcohol in Japan was 7.2 l (male 10.4 l vs female
4.2 l) and in China was 6.7 l (male 10.9 l vs female 2.2 l)
compared to less than 1.0 l in Saudi Arabia, Iran,
Pakistan, Indonesia and Myanmar [40]. However, these
data reflect associations rather than causality and does
not take into consideration the lag time between alcohol
consumption and the development of oesophageal cancer.
Another important observation is the high incidence
of infection-related cancers, such as liver, stomach and
cervical cancers, in Eastern Asia. For example, 75–80 %
of liver cancer in Eastern and South-Eastern Asia are asso-
ciated with chronic hepatitis B virus infection [41]. This is
in contrast to the West, where alcohol consumption is the
main aetiological factor for liver cancer [37, 42]. In Japan
and Korea, where the incidence of stomach cancer is one
of the highest in Asia, the prevalence of H. Pylori infection
among asymptomatic adults aged more than 40 years is as
high as 80–90 % [43].
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In Asia, South-Central Asia has the lowest cancer inci-
dence in both men and women for all cancers except
cervical cancer. This is despite the relatively low incidence
of reported HPV infection in South Asian countries, such
as India [44]. Possible explanation for this high incidence
of cervical cancer include sexual practices and malnutri-
tion in this subregion [45, 46].
In Asia, the MIRs as well as absolute mortality rates
are particularly high in lung, liver and stomach cancers
in both men and women. Patients with these cancers
often present late as there is no effective screening
method [47]. In comparison, colorectal, breast, cervical
and prostate cancers have lower MIRs and this is
because they have a longer latency period and effective
screening methods. However, despite this, the MIRs for
breast (0.35), prostate (0.4), cervical (0.5) and colorectal
(male 0.52 vs female 0.54) cancers are high, compared to
those of the developed countries [8]. Studies have found
that in Asia, postmenopausal women with breast cancer
are more likely to be oestrogen-receptor negative, which
carry a poor prognosis, compared to those in North
America [8]. In addition, population-based breast cancer
screening programme is only available in few countries
in Asia, such as Japan, Singapore, South Korea and
Taiwan [48]. For cervical cancer, it is worrying to see
that the both the incidence and MIR were high in
South-Central Asia, of which India accounted for 27 %
of the total cervical cancer deaths in the world [1]. The
high mortality of cervical cancer in this subregion may
be attributed to unavailability of population screening
and HPV vaccine. For example, in India, Nepal and
Bangladesh, the proportion of eligible women who under-
went a pelvic examination and pap smear in the past
3 years was less than 10 % compared to 44 % in Israel
[49]. In prostate cancer, it was reported that the uptake for
prostate cancer screening in Japan remains low; the delay
in help seeking in men and, therefore, late diagnosis may
explain the higher than expected MIR [50]. For colorectal
cancer, most Asian countries do not have a structured
mass screening programme except Taiwan and South
Korea. Colorectal cancer screening is provided freely in
Taiwan and subsidised in South Korea [51].
There are several limitations in this study. There is a
wide variation in data quality and accuracy from GLO-
BOCAN. Only a small number of Asian countries have
data on cancer incidence rates in the CI5 database, and
only a few have complete national death data. In
addition, we also excluded several countries from the
correlation analysis of income vs MIR because the re-
ported MIR was more than 1.0.
Conclusions
This study confirms that there is a wide variation in can-
cer incidence and mortality across Asia. This raises the
concern that the rapidly developing and westernised
Asia may be facing a ‘cancer epidemic’ in the near
future. While the more developed and higher income
countries in Eastern and Western Asia still register a
higher cancer incidence than the less developed and
lower income South-Central and some South-Eastern
Asia countries, the latter struggle to cope as evidenced
by the high MIR. This is particularly worrying as life-
style- and infection-related aetiological factors remain
uncurbed in these resource-poor countries.
This calls for an urgent investigation into the causes of
high cancer MIR in South-eastern and South-central
subregions as well as low income countries in Asia so
that effective interventions can be developed to improve
cancer survival. More systematic and accurate collection
of epidemiological data are necessary to monitor the
trend and evaluate the effectiveness of these interven-
tions. This is a task that requires collaborations between
local government and local, regional and international
non-governmental organisation, such as WHO. There
should be a platform for countries within and outside
Asia to share and brainstorm strategies to improve can-
cer detection and survival so as to reduce the burden of
cancer on individuals, family and the nation.
Additional file
Additional file 1: Data sources and methods for estimating
incidence and mortality rates for each Asian country. (DOCX 26 kb)
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